Psoriasis Market 2024-2034

1
Psoriasis MarketResearch Report 2024-2034
2
ABOUT IMARC
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights

• Psoriasis Market Report Overview
• Report Attribute Details
• Base Year
  2023
• Forecast Years 2024-2034
• Historical Years 2018-2023
• Market Size in 2023 US
  19.2 Billion
• Market Forecast in 2034 US 35.8
  Billion
• Market Growth (2024-2034) 5.85
• The report offers a comprehensive analysis of the
  Psoriasis market in the United States, EU5
  (including Germany, Spain, Italy, France, and the
  United Kingdom), and Japan. It covers aspects
  such as treatment methods, drugs available in the
  market, drugs in development, the proportion of
  various therapies, and the market's performance
  in the seven major regions. Additionally, the
  report evaluates the performance of leading
  companies and their pharmaceutical products.
  Current and projected patient numbers across
  these key markets are also detailed in the
  report.

4
Report Description and Highlights

• This study is essential for manufacturers,
  investors, business planners, researchers,
  consultants, and anyone interested or involved in
  the Psoriasis market.
• Market Overview
• The 7 major psoriasis markets reached a value of
  US 19.2 Billion in 2023. Looking forward, IMARC
  Group expects the 7MM to reach US 35.8 Billion
  by 2034, exhibiting a growth rate (CAGR) of 5.85
  during 2024-2034.

5
Report Description and Highlights

• Psoriasis refers to a chronic, immune-mediated
  disease in which skin cells build up and develop
  scales and itchy, dry patches. The psoriasis
  market has experienced significant growth in
  recent years. This expansion is attributed to
  various pivotal factors that continue to shape
  the landscape of psoriasis treatment. A major
  catalyst propelling market growth is the
  increasing prevalence of psoriasis. This
  condition affects a substantial number of
  individuals worldwide each year, resulting in a
  significant patient population in need of
  effective medications. Continuous research
  endeavors have yielded a deeper understanding of
  the underlying mechanisms of psoriasis, leading
  to the development of advanced therapies. These
  advancements offer patients enhanced medication
  options and improved outcomes. The introduction
  of biological drugs and targeted therapies has
  brought about a revolution in psoriasis
  treatment. Medical interventions such as TNF
  inhibitors and IL-17 inhibitors demonstrate
  higher efficacy and fewer side effects compared
  to traditional drugs like topical steroids.
• Greater awareness about psoriasis and its impact
  on an individuals quality of life has encouraged
  more people to seek medications. This heightened
  awareness has reduced the stigma associated with
  the condition and promoted early intervention.

6
Report Description and Highlights

• Many governments and insurance providers now
  offer favorable reimbursement policies for
  psoriasis medications, making them easily
  accessible to patients who may face financial
  constraints related to diagnosis and treatment.
  Technological innovations, including telemedicine
  and digital health platforms, have improved
  patient access to dermatologists and streamlined
  disease monitoring. The psoriasis market is
  expanding rapidly in emerging economies where
  healthcare infrastructure is growing, granting
  more patients access to advanced medicines. A
  robust pipeline of novel psoriasis medications is
  fueling optimism in the market. New drugs and
  therapies with different mechanisms of action are
  at various stages of development, promising
  improved options for patients and healthcare
  providers. Collectively, these efforts and
  factors are poised to drive the growth of the
  psoriasis market in the coming years.
• Request a Sample Report https//www.imarcgroup.co
  m/psoriasis-market/requestsample

7
Report Description and Highlights

• What is included in the report segmentation?
• The report covers the following aspects
• Report Period
• Base Year 2023
• Historical Period 2018-2023
• Market Forecast 2024-2032
• Countries Included
• United States
• Germany
• France

8
Report Description and Highlights

• United Kingdom
• Italy
• Spain
• Japan
• Analysis Covered Across Each Country
• Historical, current, and future epidemiology
  scenario
• Historical, current, and future performance of
  the Psoriasis market
• Historical, current, and future performance of
  various therapeutic categories in the market
• Sales of various drugs across the Psoriasis
  market
• Reimbursement scenario in the market
• In-market and pipeline drugs
• This report also provides a detailed analysis of
  the current Psoriasis marketed drugs and
  late-stage pipeline drugs.

9
Report Description and Highlights

• In-Market Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
• Late-Stage Pipeline Drugs
• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/psoriasis-market

10
Report Description and Highlights

• Competitive Landscape With Key Players
• The competitive landscape of the Psoriasis market
  has been studied in the report with the detailed
  profiles of the key players operating in the
  market.
• Ask Analyst for Customization and Explore Full
  Report With TOC List of Figures
  https//www.imarcgroup.com/request?typereportid
  7295flagC
• If you need specific information that is not
  currently within the scope of the report, we will
  provide it to you as a part of the customization.
• About Us
• IMARC Group is a leading market research company
  that offers management strategy and market
  research worldwide. We partner with clients in
  all sectors and regions to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  pharmaceuticals, food and beverage, travel and
  tourism, nanotechnology and novel processing
  methods are at the top of the companys expertise.

11
Report Description and Highlights

• Media Contact
• Company Name IMARC Group
• Contact Person Elena Anderson
• Email sales_at_imarcgroup.com
• Phone [phone]
• Address 134 N 4th St
• City Brooklyn
• State NY
• Country United States
• Website https//www.imarcgroup.com/

12
Key Questions Answered in the Report

1. How has the Psoriasis market performed so far and
   how will it perform in the coming years?
2. What are the markets shares of various
   therapeutic segments in 2023 and how are they
   expected to perform till 2034?
3. What was the country-wise size of the Psoriasis
   market across the seven major markets in 2023 and
   what will it look like in 2034?
4. What is the growth rate of the Psoriasis market
   across the seven major markets and what will be
   the expected growth over the next ten years?
5. What are the key unmet needs in the market?

13
Table of Contents
14
Table of Contents

• 1 Preface
• 2 Scope and Methodology
• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
• 2.3.1 Primary Sources
• 2.3.2 Secondary Sources
• 2.4 Market Estimation
• 2.4.1 Bottom-Up Approach
• 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology
• 3 Executive Summary

15
Table of Contents

• 4 Psoriasis - Introduction
• 4.1 Overview
• 4.2 Regulatory Process
• 4.3 Epidemiology (2018-2023) and Forecast
  (2024-2034)
• 4.4 Market Overview (2018-2023) and Forecast
  (2024-2034)
• 4.5 Competitive Intelligence
• 5 Psoriasis - Disease Overview
• 5.1 Introduction
• 5.2 Symptoms and Diagnosis
• 5.3 Pathophysiology
• 5.4 Causes and Risk Factors
• 5.5 Treatment
•    Click here to visit the complete table of
  content with list of figures and tables
  https//www.imarcgroup.com/psoriasis-market/toc

16
Partial List Of Our Clients
17
OUR CLIENTS
18
Disclaimer
2024 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.